Circulating Tumor DNA Testing Opens New Perspectives in Melanoma Management

Malignant melanoma accounts for about 1% of all skin cancers, but it causes most of the skin cancer-related deaths. Circulating tumor DNA (ctDNA) testing is emerging as a relevant tool for the diagnosis and monitoring of cancer. The availability of highly sensitive techniques, including next generat...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Alessandra Sacco, Laura Forgione, Marianeve Carotenuto, Antonella De Luca, Paolo A. Ascierto, Gerando Botti, Nicola Normanno
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI AG 2020-10-01
Serie:Cancers
Soggetti:
ctDNA
melanoma
liquid biopsy
prognosis
prediction
patient stratification
Accesso online:https://www.mdpi.com/2072-6694/12/10/2914
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi